Last reviewed · How we verify

NCT04668378

Effects of a Time Restricted Eating Protocol on Resistance Training Men

Completed NA Last updated 17 December 2020
What this trial tests

NA trial testing Time restricted eating in Fasting in 34 participants. Completed in 31 August 2017.

Timeline
1 January 2014
Primary endpoint
31 March 2015
31 August 2017

Quick facts

Lead sponsorUniversity of Padova
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment34
Start date1 January 2014
Primary completion31 March 2015
Estimated completion31 August 2017
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Padova

Who can join

Adults 20 to 40, male only, with Fasting or Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study sought to investigate the effects of 16/8 time restricted eating (TRE) with windows of 16 hours of fasting and 8 hours of eating on on body composition, muscle strength, and metabolic factors during resistance training in healthy resistance trained males

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Twelve Months of Time-restricted Eating and Resistance Training Improves Inflammatory Markers and Cardiometabolic Risk Factors.
    Moro T, Tinsley G, Pacelli FQ, Marcolin G, et al · · 2021 · cited 93× · PMID 34649266 · DOI 10.1249/mss.0000000000002738

Verify or expand the search:

Other trials of Time restricted eating

Trials testing the same drug.

Other recruiting trials for Fasting

Currently open trials in the same condition.

Other University of Padova trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04668378.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing